As a result, the FDA concluded that these products were misbranded under sections 502(a) and 502(bb) of the FDCA [21 U.S.C
Some people, specifically those with PCOS, actually see improvements to their periods
Choosing the Right GLP1 Agent When selecting a GLP1 for liver-focused treatment, clinicians should consider the agents weight loss efficacy, clinical trial evidence related to liver outcomes, and patient comorbidities
Thats rare in this space and signals real confidence in the product
Higher upside narrative: the Phase 2 results made it feel like a major leap, not a minor refinement
(Once glycogen runs out, the body switches to deriving energy from fat, a process known as ketosis.) The bodys glycogen stores and water weight return if carbs are reintroduced